NCT00719745View on ClinicalTrials.gov

A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Liver Transplantation
Interventions
DRUG

Prograf

oral

DRUG

MR4

oral

Trial Locations (1)

Unknown

Seoul

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY